FGEN

Filed a patent for "[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid (roxadustat) for the treatment of chemotherapy-induced anemia (cia)" on Wed, May 17, 2023

Filed a patent for "[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid (roxadustat) for the treatment of chemotherapy-induced anemia (cia)" on Mon, July 31, 2023

Filed a patent for "connective tissue growth factor antibodies" on Thu, March 7, 2024

Filed a patent for "compounds, compositions and methods for histone lysine demethylase inhibition" on Thu, January 4, 2024

Filed a patent for "enhanced erythropoiesis and iron metabolism" on Thu, June 6, 2024

Filed a patent for "modified anti-galectin-9 antibody and uses thereof" on Fri, July 15, 2022

Filed a patent for "modified anti-galectin-9 antibody and uses thereof" on Fri, July 15, 2022

Filed a patent for "anti-ccr8 antibodies and uses thereof" on Fri, August 19, 2022